Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Licensing Strategies: Benchmarking Analysis of the Top Pharmaceutical Companies' returned 112 results - Page 1 of 6   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines   GBI Research, April 2011, Pages: 105 Pharmaceuticals Ltd 101 10.10.1 Company Overview 101 10.10.2 Licensing Agreements 101 11 Biotech M&A and Licensing Strategies – Appendix 102 11.1 Marketed Definitions 102 11.2 Abbreviations 102 11 Pharmaceutical Packaging Industry - 2011 Yearbook   GBI Research, Dec 2011, Pages: 76 the benchmarking of top companies, key trends on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging. Global Pharmaceutical Packaging Industry to Record Growth with Rapid Expansion Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013   GBI Research, Sep 2011, Pages: 85 . The report analyzes the effective strategies that shape the industry dynamics. Further, the report provides competitive benchmarking for the leading companies and analyzes the M&A and strategic partnerships Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force   GBI Research, Aug 2011, Pages: 108 and challenges in the Indian pharmaceutical industry. The report analyzes effective strategies adopted by industry participants that shape industry dynamics. Further, the report provides competitive benchmarking The Future of the Pharmaceutical Packaging Industry - Emerging Economies Poised to Capitalize on Increasing Demand   GBI Research, Dec 2009, Pages: 62 and developmental issues are also addressed. The report provides an in-depth analysis of the competitive landscape, including the benchmarking of top companies, key trends on mergers and acquisitions, and licensing EvaluatePharma® Yearbook - Company Performance Tables   Biopharm Knowledge Publishing, July 2008, Pages: 140 Appendix 1 Total pharmaceutical sales (2007) showing sales from Rx, OTC, total Rx & OTC, alliance/co-promotion, royalty & licensing and other pharma (including bulk sales) Appendix 2.1 Top companies Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators   GBI Research, Nov 2010, Pages: 85 companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. The report is based on proprietary databases, primary and secondary research and in-house analysis Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies   GBI Research, Oct 2010, Pages: 120 Pharmaceutical Companies' Adoption of New Sales Models and Technologies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the sales force effectiveness strategies The Outlook for Pharmaceuticals in North East Asia   Espicom Business Intelligence Ltd, Nov 2011 development, manufacturing and trade COMPETITION Trade associations, trade fairs, company intelligence and competitive strategies OTC PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D   GBI Research, Nov 2011, Pages: 160 , investments and strategic partnerships - Develop key strategic initiatives by studying the key strategies of top competitors - Reinforce R&D pipelines by identifying licensing strategies for acquiring new Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets   GBI Research, Aug 2010, Pages: 132 development. - Competitive benchmarking of leading companies. The key companies studied in this report are Merck, Pfizer, Johnson & Johnson, Teva Pharmaceuticals and Bayer-Schering Pharma. - Key M&A activities Men's Health Therapeutics Market to 2016 - Selective Serotonin Reuptake Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors Will Dominate the Market   GBI Research, Aug 2010, Pages: 138 provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information Early Stage and Discovery Deals: Strategy, Structure and Payment Terms, 2nd Edition   Pharmalicensing Ltd., Dec 2006, Pages: 144 Today early-stage partnering is a core component of both biotech and pharmaceutical business strategy, allowing companies to access promising new and emerging compounds and technologies. To become The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis   GBI Research, Dec 2009, Pages: 91 “The Future of Global Vaccines - Market Forecasts to 2015, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis” provides insights on the global vaccines sales, volume and price Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market   GBI Research, Dec 2010, Pages: 97 explores the competitive landscape, with a competitive analysis of the top companies in the market. Finally, a key trend analysis of mergers and acquisitions, and licensing agreements in the contraceptives Successful Pharmabiotech Alliance Strategies: Driving Synergies, Avoiding Failure and Managing Relationships   Business Insights, Sep 2008, Pages: 143 ’s analysis of current and future biotech positions of the top ten pharmaceutical companies and a detailed evaluation of recent major joint ventures, acquisitions and licensing deals. - Understand the future Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs   GBI Research, Sep 2011, Pages: 168 v/s Turnover for the Top Ten Pharmaceutical Companies by Revenue in 2010, 2004–2010 15 Figure 4: Major Pricing and Reimbursement Strategies Employed Across the Globe, 2011 17 Figure 5: ISPOR 33 The Specialty Pharma Market Outlook: Key Players, New Company Growth Models and Emerging Opportunities   Business Insights, Oct 2006, Pages: 199 are the key emerging strategies for pharmaceutical companies to establish a presence and operate within the specialty pharmaceutical market in the future? Top 5 Reasons to Order your Copy Today: - Gain The Fastest Growing Biotechnology Companies: Growth Strategies, Comparative Analyses and Company Profiles   Business Insights, March 2008, Pages: 280 biotech companies, benchmark their most successful strategies and understand major industrial issues with this new report. Top five reasons to order your copy today - Identify the fastest growing biotech Winning R&D Productivity Strategies: Exploiting innovation, licensing and outsourcing opportunities   Business Insights, Oct 2006, Pages: 136 -Licensing deals are increasing in complexity and value. The average value of deals have also increased over the last few years as indicated by $194m increase in average value of the top 10 pharmaceutical Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network